Pubrio sells to AI agents - live prices and self-serve payment

The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.

pubrio
BioVentrix logo

BioVentrix

+1
Medical Devices22 employeesFounded 2003🇺🇸 United States
Headquarters
🇺🇸120 Forbes Blvd, Mansfield, Massachusetts 02048, Us (+1)
Industry
Medical Devices
Employees
22
Founded
2003
Ranking
#1,792,666

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

Specialties
Medical DevicesPharmaceuticalsHealthcare

Expansion Intelligence

NEW · only on Pubrio

We're tracking BioVentrix's market expansion

Global expansion

Live
Last 90 days
Stages
Exploring0Committing0Expanding0Scaling0
Recent activity
Advancing30d
New90d

Activity pulse

2 signals in the last 90 days.

Last 90 days
Hiring
0
No activity
Marketing & PR
0
No activity
Product & Tech
2↓ Ended
Cloud footprint
+2more categoriesLocked
3 of 5 shown
Good to know

Frequently Asked Questions Regarding BioVentrix

Quick answers about BioVentrix's business, markets, and growth signals.

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

800M+
Companies watched
50+
Local data sources
16
Movement signals
Daily
Refresh
“We reach accounts the week they land in-market — not the quarter after.”
Head of Growth · a 500+ revenue team on Pubrio

See the world’s companies move.

Book a walkthrough of the movement map with our team.

pubrio

Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.

Follow

Ask AI about Pubrio

For AI agents

Pubrio - Agent Storefront, powered by ZeroClick

© 2026 Pubrio. All rights reserved.